Article (Scientific journals)
The ribonucleoside diphosphate reductase inhibitor (E)-2'-Deoxy-(fluoromethylene) cytidine, acts as a cytotoxic radiosensitizer on human cancer cell lines in vitro.
Coucke, Philippe; Decosterd, L-A; Li, Y-X et al.
1999In Cancer Research, 59, p. 5219-5226
Peer Reviewed verified by ORBi
 

Files


Full Text
the ribonucleoside diphosphate reductase inhibitor vol 59 1999.pdf
Author postprint (150.06 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
radiotherapy; radiosensitization; deoxynucleotide; FMdC; DNA Synthesis
Abstract :
[en] ABSTRACT (E)-2*-Deoxy-(fluoromethylene)cytidine (FMdC) is known as an inhibitor of ribonucleoside diphosphate reductase, a key enzyme in the de novo pathway of DNA synthesis. FMdC was tested as a modifier of radiation response in vitro on a human colon carcinoma cell line (WiDr), and the observed radiosensitization was confirmed on two human cervix cancer cell lines (C33-A and SiHa). Using the clonogenic assay, the effect ratio (ER) at a clinically relevant dose level of 2 Gy was 2.10 (50 nM FMdC), 1.70 (30 nM FMdC), and 1.71 (40 nM FMdC) for the three cell lines WiDr, C33-A, and SiHa, respectively. A more detailed analysis of the importance of timing and concentration of FMdC was done on the WiDr cell line alone, yielding an increased ER(2Gy) with increasing concentration and duration of exposure to the drug, ranging from 1.0 (6 h) to 1.8 (72 h) at 30 nM FMdC and from 1.2 (6 h) to 3.5 (24 h) at 300 nM. We investigated the effect of FMdC on the cellular deoxynucleotide triphosphate pool in WiDr cells and demonstrated a marked depletion of dATP and a significant rise of TTP levels. Cell cycle analysis showed early S-phase accumulation induced by FMdC alone, G2-M block induced by irradiation alone, and an increased accumulation of cells in G2-M if both modalities are used. Our data suggest that FMdC is a radiation response modifier in vitro on different cancer cell lines. The observed radiosensitization may in part be explained by alteration of the deoxynucleotide triphosphate pool, which is consistent with the effect of FMdC on ribonucleoside diphosphate reductase.
Disciplines :
Oncology
Hematology
Author, co-author :
Coucke, Philippe  ;  Centre Hospitalier Universitaire Vaudois
Decosterd, L-A
Li, Y-X
Cottin, E
Chen, X
Sun, L-Q
Stern, S
Paschoud, N
Denekamp, J
Language :
English
Title :
The ribonucleoside diphosphate reductase inhibitor (E)-2'-Deoxy-(fluoromethylene) cytidine, acts as a cytotoxic radiosensitizer on human cancer cell lines in vitro.
Publication date :
1999
Journal title :
Cancer Research
ISSN :
0008-5472
eISSN :
1538-7445
Publisher :
American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland
Volume :
59
Pages :
5219-5226
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 15 July 2009

Statistics


Number of views
43 (1 by ULiège)
Number of downloads
100 (0 by ULiège)

Scopus citations®
 
13
Scopus citations®
without self-citations
10

Bibliography


Similar publications



Contact ORBi